Standard practice and controversial issues in front-line therapy of acute promyelocytic leukemia

Miguel A. Sanz, Francesco Lo Coco

Research output: Contribution to journalArticle

Abstract

In addition to choosing a state-of-the-art regimen including all-trans retinoic acid and anthracycline chemotherapy, modern management of acute promyelocytic leukemia (APL) implies the adoption of appropriate supportive measures, rapid establishment of an accurate genetic diagnosis, correct assessment of response to therapy and evaluation of the risk of disease recurrence by molecular monitoring. However, the general consensus about this overall strategy for APL treatment still leaves room for debate. In the present article, we review the current standard practice and controversial issues in the treatment of patients with newly diagnosed APL, including the management of special situations such as elderly patients, children and pregnant women.

Original languageEnglish
JournalHaematologica
Volume90
Issue number6
Publication statusPublished - Jun 2005

Keywords

  • ALK1
  • Angiogenesis
  • Hereditary hemorrhagic telangiectasia (HHT)
  • TGF-β1
  • VEGF

ASJC Scopus subject areas

  • Hematology

Fingerprint Dive into the research topics of 'Standard practice and controversial issues in front-line therapy of acute promyelocytic leukemia'. Together they form a unique fingerprint.

  • Cite this